Stryker forecasts 2025 profit above estimates on robust demand for surgical devicesReuters • 01/28/25
Stryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international businessGlobeNewsWire • 01/28/25
Stryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial OfficerGlobeNewsWire • 01/28/25
Stryker: A Cool Name For An Awesome Company, But Is It A Buy Ahead Of Earnings?Seeking Alpha • 01/27/25
Stryker (SYK) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresZacks Investment Research • 01/23/25
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.GlobeNewsWire • 01/17/25
INARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc. - NARIBusiness Wire • 01/07/25
Stryker Stock Falls Despite the Agreement to Acquire Inari MedicalZacks Investment Research • 01/07/25
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism PositionBenzinga • 01/07/25
Inari Medical Catapults — Again — After Stryker Confirms $4.9 Billion DealInvestors Business Daily • 01/06/25
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segmentGlobeNewsWire • 01/06/25
Exclusive: Medical device maker Stryker nearing a deal to buy Inari Medical, sources sayReuters • 01/06/25
Here's Why You Should Retain Stryker Stock in Your Portfolio for NowZacks Investment Research • 12/17/24
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And GlaukosBenzinga • 12/02/24